| Multiple | Now | Sector median | Where it sits |
|---|---|---|---|
| P/E | 52.8× | −1.7× | |
| Price / Book | 8.4× | 2.0× | |
| Price / Sales | 15.0× | 3.9× | |
| Price / Free cash flow | 60.5× | −1.6× | |
| EV / EBITDA | 37.0× | −1.2× | |
| Earnings yield | 1.9% | −14.6% | |
| Free cash flow yield | 1.7% | −9.9% |
| Company | Price | Change | Mkt cap (USD) | P/E | ROE | 1Y |
|---|---|---|---|---|---|---|
LLNYSE:LLYEli Lilly and Co · 🇺🇸 NYSE | $1,251.65 | −0.43% | $1.18T | 57.3× | 77.8% | +16.7% |
JNNYSE:JNJJohnson & Johnson · 🇺🇸 NYSE | $254.31 | −0.49% | $612.86B | 23.0× | 32.9% | +33.7% |
ABNYSE:ABBVAbbVie Inc · 🇺🇸 NYSE | $284.45 | −0.34% | $502.66B | 119.3× | −129.2% | +26.2% |
UNNYSE:UNHUnitedHealth Group Inc · 🇺🇸 NYSE | $404.69 | +0.81% | $363.25B | 29.9× | 12.8% | +11.2% |
MRNYSE:MRKMerck & Co Inc · 🇺🇸 NYSE | $144.53 | −0.97% | $356.58B | 19.7× | 34.7% |
NVNYSE:NVSNovartis AG · 🇺🇸 NYSE | $150.55 | −0.05% | $278.5B | 19.8× | 30.5% | +15.9% |
AZNYSE:AZNAstraZeneca PLC · 🇺🇸 NYSE | $164.93 | −0.29% | $255.79B | 25.0× | 21.1% | −2.2% |
TMNYSE:TMOThermo Fisher Scientific Inc · 🇺🇸 NYSE | $679.23 | −1.56% | $251.14B | 37.9× | 12.6% | +30.7% |
AMNAS:AMGNAmgen Inc · 🇺🇸 NAS | $428.25 | −0.98% | $231.53B | 30.3× | 89.1% | +45.5% |
GINAS:GILDGilead Sciences Inc · 🇺🇸 NAS | $154.73 | −0.93% | $191.86B | 22.8× | 37.5% | +32.0% |
